Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Inventory Average (2016 - 2025)

Historic Inventory Average for Corcept Therapeutics (CORT) over the last 10 years, with Q3 2025 value amounting to $12.3 million.

  • Corcept Therapeutics' Inventory Average rose 5015.24% to $12.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.3 million, marking a year-over-year increase of 5015.24%. This contributed to the annual value of $10.1 million for FY2024, which is 4563.99% up from last year.
  • Per Corcept Therapeutics' latest filing, its Inventory Average stood at $12.3 million for Q3 2025, which was up 5015.24% from $13.3 million recorded in Q2 2025.
  • Corcept Therapeutics' 5-year Inventory Average high stood at $13.4 million for Q1 2025, and its period low was $4.8 million during Q2 2021.
  • In the last 5 years, Corcept Therapeutics' Inventory Average had a median value of $6.7 million in 2023 and averaged $7.5 million.
  • Per our database at Business Quant, Corcept Therapeutics' Inventory Average plummeted by 618.58% in 2021 and then surged by 7949.06% in 2025.
  • Corcept Therapeutics' Inventory Average (Quarter) stood at $5.0 million in 2021, then grew by 21.68% to $6.1 million in 2022, then rose by 25.5% to $7.6 million in 2023, then surged by 34.24% to $10.2 million in 2024, then increased by 20.35% to $12.3 million in 2025.
  • Its last three reported values are $12.3 million in Q3 2025, $13.3 million for Q2 2025, and $13.4 million during Q1 2025.